Medtronic can't shake shareholders lawsuit over Infuse (MassDevice)
A federal judge green-lights a shareholders lawsuit over its Infuse bone-growth protein that accuses Medtronic and its management, including former CEO William Hawkins, of misleading investors about Infuse's safety risks and commercial upside.
A federal judge in Minneapolis has green-lighted a shareholder suit over Medtronic's (NYSE:MDT) handling of its Infuse bone-growth product.
Although he tossed some claims, Judge John Tunheim ruled that the suit can proceed against Medtronic and several of its top executives, including fo...
